Talaris Therapeutics Price on March 20, 2023

TALSDelisted Stock  USD 2.98  0.10  3.25%   
If you're considering investing in Talaris Stock, it is important to understand the factors that can impact its price. As of today, the current price of Talaris Therapeutics stands at 2.98, as last reported on the 30th of December, with the highest price reaching 3.08 and the lowest price hitting 2.98 during the day. We have found twenty-nine technical indicators for Talaris Therapeutics, which you can use to evaluate the volatility of the company. Please validate Talaris Therapeutics' Semi Deviation of 3.08, coefficient of variation of 846.74, and Risk Adjusted Performance of 0.1025 to confirm if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Talaris Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
TALS
Based on monthly moving average Talaris Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Talaris Therapeutics by adding Talaris Therapeutics to a well-diversified portfolio.

Related Headline

CytomX Therapeutics Headline on 20th of March 2023

Filed transaction by Cytomx Therapeutics Inc officer. General open market or private sale of non-derivative or derivative security

Talaris Therapeutics Valuation on March 20, 2023

It is possible to determine the worth of Talaris Therapeutics on a given historical date. On March 20, 2023 Talaris was worth 1.96 at the beginning of the trading date compared to the closed value of 1.9. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Talaris Therapeutics stock. Still, in general, we apply an absolute valuation method to find Talaris Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Talaris Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Talaris Therapeutics' related companies.
 Open High Low Close Volume
  1.86    2.15    1.84    2.09    346,783  
03/20/2023
  1.96    1.96    1.83    1.90    68,800  
  1.90    1.92    1.82    1.85    73,200  
Backtest Talaris Therapeutics  |  Talaris Therapeutics History  |  Talaris Therapeutics Valuation   PreviousNext  
Open Value
1.96
1.9
Closing Value
1.96
Upside

Talaris Therapeutics Trading Date Momentum on March 20, 2023

On March 21 2023 Talaris Therapeutics was traded for  1.85  at the closing time. The top price for the day was 1.92  and the lowest listed price was  1.82 . The trading volume for the day was 73.2 K. The trading history from March 21, 2023 was a factor to the next trading day price decrease. The trading price change against the next closing price was 2.63% . The trading price change against the current closing price is 5.79% .

Talaris Therapeutics Fundamentals Correlations and Trends

By evaluating Talaris Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Talaris Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Talaris financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Talaris Therapeutics Stock history

Talaris Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Talaris is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Talaris Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Talaris Therapeutics stock prices may prove useful in developing a viable investing in Talaris Therapeutics
Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. Talaris Therapeutics, Inc. was founded in 1988 and is headquartered in Louisville, Kentucky. Talaris Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 128 people.

Talaris Therapeutics Stock Technical Analysis

Talaris Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Talaris Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Talaris Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Talaris Therapeutics Period Price Range

Low
December 30, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Talaris Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Talaris Therapeutics December 30, 2024 Market Strength

Market strength indicators help investors to evaluate how Talaris Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Talaris Therapeutics shares will generate the highest return on investment. By undertsting and applying Talaris Therapeutics stock market strength indicators, traders can identify Talaris Therapeutics entry and exit signals to maximize returns

Talaris Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Talaris Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Talaris Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Talaris to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Consideration for investing in Talaris Stock

If you are still planning to invest in Talaris Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Talaris Therapeutics' history and understand the potential risks before investing.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.